Sunday, February 12, 2017
Washington State Convention Center
SEATTLE
Carl Dieffenbach; Director, Division of AIDS, NIH
Welcome
[video] [audio-only/slide]
Charles Flexner, Johns Hopkins University
Where will we LEAP to next?! Overview of Workshop
[video] [audio-only/slide]
Peter Williams (Janssen)
Current Status of Clinical Development of LA-Rilpivirine?
[video/slides] [audio-only/slide]
Bill Spreen, (ViiV Healthcare)
Current Status of Clinical Development of LA-Cabotegravir
[video/slides] [audio-only/slide]
Susan Swindells, University of Nebraska Medical Center
LEAP TB – Update from the LEAP Working Group on Development of Long-Acting Approaches to the Treatment of Tuberculosis
[video/slides] [audio-only/slide]
Marco Siccardi, University of Liverpool
Update from the LEAP Modeling and Simulation Core: The use of Physiologically-based Pharmacokinetic
and Pharmacodynamic Modelling to Assess Drug Candidates
[video/slides] [audio-only/slide]
Richard Koup, Vaccine research Center, Division of AIDS
LA-VRC01 – Development of a long-acting broadly neutralizing anti-HIV monoclonal antibody for parenteral administration
[video/slides] [audio-only/slide]
Larry Corey, University of Washington
Clinical development of broadly neutralizing monoclonal antibodies for HIV treatment and prevention
[video/slides] [audio-only/slide]
Howard Gendelman, University of Nebraska
LASER ART
[video/slides] [audio-only/slide]
Dirk Hair-Donald Loveday, Celanese Corporation
Polymer chemistry as a platform for LA/ER drug delivery
[video/slides] [audio-only/slide]
Nicolas Pacelli, Microchips Biotech
Programmable Microchips
[video/slides] [audio-only/slide]
Rahul Bakshi, Johns Hopkins University
LATE BREAKER: Long-acting parenteral atovaquone nanoformulation for malaria prophylaxis
[Presentation withheld at speaker's request, until further notice]
FOCUS GROUPS
Polly Clayden, Rapporteur
To Inject or to Implant, That Is the Question
[video/slides] [audio-only/slide]
Jeff Jacobson, Rapporteur
What to do about the ‘Tail?’ Coverage for missed doses and regimen changes
[video/slides] [audio-only/slide]
Susan Swindells, Rapporteur
Resistance to LA/ER ARV drugs: What is the risk, and how can this be prevented?
[video/slides] [audio-only/slide]